Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 9/20 | 0.63 |
| ▸ | BRD4 | O60885 | 9/20 | 0.63 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.55 |
| ▸ | PDGFRA | P16234 | 2/20 | 0.55 |
| ▸ | ABL1 | P00519 | 1/20 | 0.55 |
| ▸ | KIT | P10721 | 1/20 | 0.55 |
| ▸ | SRC | P12931 | 1/20 | 0.55 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.55 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.54 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.53 |
| ▸ | CDK4 | P11802 | 4/20 | 0.52 |
| ▸ | AURKA | O14965 | 3/20 | 0.52 |
| ▸ | AXL | P30530 | 1/20 | 0.51 |
| ▸ | PTK2 | Q05397 | 2/20 | 0.50 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.49 |
| ▸ | CDK1 | P06493 | 1/20 | 0.49 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.49 |
| ▸ | CCND1 | P24385 | 1/20 | 0.49 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.49 |
| ▸ | CDK2 | P24941 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4290087 | 0.91 | JAK2 (0.53) | JAK2BRD4PDGFRBPDGFRAABL1 | |
| SCHEMBL1655106 | 0.90 | RPS6KA3 (0.54) | JAK2BRD4RPS6KA3CDK4PTK2 | |
| SCHEMBL1655879 | 0.87 | JAK2 (0.65) | JAK2BRD4PDGFRBPDGFRAABL1 | |
| SCHEMBL1655325 | 0.87 | JAK2 (0.57) | JAK2BRD4RPS6KA3CDK4AURKA | |
| SCHEMBL1655850 | 0.87 | BRD4 (0.65) | JAK2BRD4RPS6KA3CDK4AURKA | |
| SCHEMBL1657481 | 0.85 | JAK2 (0.67) | JAK2BRD4PDGFRBPDGFRAABL1 | |
| SCHEMBL1657551 | 0.85 | AURKA (0.59) | JAK2BRD4RPS6KA3FGFR4CDK4 | |
| SCHEMBL1655182 | 0.84 | JAK2 (0.52) | JAK2BRD4PDGFRBPDGFRAABL1 | |
| SCHEMBL27915943 | 0.83 | JAK2 (0.51) | JAK2BRD4RPS6KA3CDK4AURKA | |
| SCHEMBL1655039 | 0.82 | RPS6KA3 (0.61) | JAK2BRD4RPS6KA3CDK4PTK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090203688-A1 | HETEROCYCLIC COMPOUNDS | NOVARTIS AG | 2009-08-13 | — | — | US | claimed |
| CN-101981036-B | Pyrrolo [2, 3-D] pyridines and use thereof as tyrosine kinase inhibitors | NOVARTIS AG | 2013-09-04 | — | — | CN | disclosed |
| US-8420657-B2 | Pyrrolo[2,3-D]pyrimidines and use thereof as tyrosine kinase inhibitors | NOVARTIS AG (CH) | 2013-04-16 | — | — | US | disclosed |
| US-20090203688-A1 | HETEROCYCLIC COMPOUNDS | NOVARTIS AG | 2009-08-13 | — | — | US | disclosed |
| US-20090203688-A1 | HETEROCYCLIC COMPOUNDS | NOVARTIS AG | 2009-08-13 | — | — | US | disclosed |
| WO-2009098236-A1 | PYRROLO [2, 3-D] PYRIDINES AND USE THEREOF AS TYROSINE KINASE INHIBITORS | NOVARTIS AG (CH) | 2009-08-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090203688-A1 | HETEROCYCLIC COMPOUNDS | ABL1, JAK2, JAK1 | JAK2 2/4885BRD4 964/4885PDGFRB 433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.